Amplia Therapeutics is a biopharmaceutical company focused on the development of therapies for the treatment of autoimmune and inflammatory conditions. Their operations involve discovering, developing, and commercializing drug candidates, while their projects involve research and development of novel therapies. Their primary objective is to develop therapies that improve the lives of patients suffering from these conditions.